XML 24 R42.htm IDEA: XBRL DOCUMENT v3.3.0.814
SHARE-BASED COMPENSATION (Narrative) (Detail)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2015
USD ($)
shares
Sep. 30, 2014
USD ($)
Sep. 30, 2015
USD ($)
Directors
$ / shares
shares
Sep. 30, 2014
USD ($)
$ / shares
Dec. 31, 2014
USD ($)
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Weighted-average grant-date fair value of stock options | $ / shares     $ 14.40 $ 16.46  
Cash received from stock options exercised     $ 9.9 $ 14.3  
1993 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares reserved for issuance | shares 7,400,000   7,400,000    
Shares reserved for issuance for all outstanding share-based compensation grants | shares 3,500,000   3,500,000    
Capitalized amount of compensation cost recognized     $ 0.6   $ 0.5
Additional paid-in capital representing excess tax benefits available to absorb potential future tax deficiencies $ 93.4   $ 93.4   89.6
Stock Options And Stock-Settled SARS          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock option grant component, percentage of market price     100.00%    
Share-based compensation arrangement by share-based payment award, award vesting rights     0.33333    
Share-based compensation arrangement by share-based payment award, award requisite service period     1 year    
Contractual life (years)     10 years    
Number of units, Granted | shares     565,408    
Weighted-average grant-date fair value of stock options | $ / shares     $ 14.40 $ 16.46  
Compensation cost (income) recognized 2.3 $ 2.4 $ 6.8 $ 6.7  
Total intrinsic value of stock options and stock-settled SARS exercised     13.7 32.4  
Unrecognized compensation cost $ 7.0   $ 7.0    
Weighted-average period to recognize total unrecognized compensation cost (years)     1 year 3 months 18 days    
Vesting period for majority of awards (years)     3 years    
Tax benefits realized     $ 5.9 10.9  
Cash received from stock options exercised     9.9 14.3  
Cash-Settled SARS          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Compensation cost (income) recognized     (0.1) (0.1)  
Cash used to settle exercises of cash-settled SARS     $ 0.1 0.7  
Liability related to cash-settled SARS         $ 0.2
Non-option awards outstanding | shares 0   0    
Performance Shares          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Non-option awards outstanding | shares 0   0    
Non-vested stock and non-vested stock units granted | shares     0   0
Nonvested Stock Units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Non-vested stock and non-vested stock units granted | shares     66,308    
Nonvested Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Non-vested stock and non-vested stock units granted | shares     13,968    
Nonvested stock granted to directors, number of directors | Directors     9    
Nonvested Stock And Nonvested Stock Units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Compensation cost (income) recognized $ 1.0 $ 1.1 $ 2.9 $ 2.9  
Unrecognized compensation cost $ 3.8   $ 3.8    
Weighted-average period to recognize total unrecognized compensation cost (years)     1 year 9 months 18 days    
Vesting period for majority of awards (years)     3 years    
Non-vested stock and non-vested stock units granted | shares     80,276    
Weighted-average grant-date fair value of nonvested stock and nonvested stock units | $ / shares     $ 45.20